CNMD logo

CNMD

CONMED CorporationNYSEHealthcare
$34.79-2.08%ClosedMarket Cap: $1.08B

As of 2026-04-06

Valuation

View Details

P/E (TTM)

22.90

PEG

P/B

1.04

P/S

0.78

EV/EBITDA

10.60

DCF Value

$143.44

FCF Yield

14.0%

Div Yield

1.1%

Margins & Returns

Gross Margin

54.6%

Operating Margin

7.5%

Net Margin

3.4%

ROE

4.7%

ROA

5.0%

ROIC

3.4%

Financials

View All
PeriodRevenueNet IncomeEPS
Q4 2025$373.2M$16.7M$0.54
FY 2025$1.37B$47.1M$1.51
Q3 2025$337.9M$2.9M$0.09
Q2 2025$342.3M$21.4M$0.69

Analyst Ratings

View All
Piper SandlerNeutral
2026-03-17
Wells FargoEqual Weight
2026-01-29
NeedhamHold
2026-01-29
B of A SecuritiesNeutral
2025-12-08
JP MorganNeutral
2025-11-06

Trading Activity

Insider Trades

View All
Beyer Patofficer: President & CEO
SellThu Apr 02
Schabacker Matthewofficer: VP GM Advanced Surgical
SellWed Mar 18
Foust Hollie Kofficer: General Counsel & Corp Sec
SellWed Mar 18
Ferrell John D.officer: Executive Vice President - HR
SellWed Mar 18
SHAGORY PETER Kofficer: EVP, STRAT & CORP DEVT
SellWed Mar 18

Company Info

Sector

Healthcare

Industry

Country

US

Exchange

NYSE

Beta

0.99

CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. It offers orthopedic surgery products, including TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and PopLok Knotless Suture Anchors, which provide unique clinical solutions to orthopedic surgeons for the repair of soft tissue injuries, as well as supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. The company markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. It also offers general surgery products, such as clinical insufflation, smoke evacuation, electrosurgical, and endomechanical products; and endoscopic technologies, including diagnostic and therapeutic products for use in gastroenterology procedures, and products for the treatment of diseases of the biliary structures, as well as cardiac monitoring products comprising ECG and EEG electrodes, and cardiac defibrillation pads. The company markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida.

Peers